Cervical Carcinoma — Trials

Cervical Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

504 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 170
Recruiting: 81
Ph III recruiting: 11
Growth YoY: +3.3%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (54)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06498661	Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)(SHIP-A-S01)	active not recruiting	N/A	750	National Cancer Institute (NCI)NIH	2	Sep 29, 2026	clinicaltrials
NCT05139368	Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer(RT-PACE)	active not recruiting	N/A	22	University of UtahOTHER	1	Sep 4, 2026